What are the limitations of the mrd assessment framework?

While the mrd assessment framework is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the mrd assessment framework to ensure safe bedside use and optimal diagnostic accuracy.

How does the mrd assessment framework compare to other Oncology scores?

The mrd assessment framework is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the mrd assessment framework free to use?

Yes. OpiCalc provides the mrd assessment framework completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

MRD Assessment Framework

Haematological Malignancies

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

MRD burden

Waiting For Required Inputs

Complete the required fields to generate the oncology interpretation.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

CLINICAL INSIGHT

How it Works

Clinical Inputs

MRD burden

Interpretive Logic

Interpret assay burden in the context of the platform used.
Trend MRD using the same assay whenever possible.

CLINICAL INSIGHT

Practical Pearls

Result Bands

<0.01%

0.01-0.09%

0.1-0.99%

>=1%

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

OpiCalc Medical Oncology ModuleHaematological Malignancies2026

CLINICAL INSIGHT

Background

Context

MRD Assessment Framework is included in the oncology module as a structured decision-support tool for haematological malignancies workflows.

No clinical reference data available.

MRD Assessment Framework

Haematological Malignancies

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

MRD burden

Waiting For Required Inputs

Complete the required fields to generate the oncology interpretation.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

CLINICAL INSIGHT

How it Works

Clinical Inputs

MRD burden

Interpretive Logic

Interpret assay burden in the context of the platform used.
Trend MRD using the same assay whenever possible.

CLINICAL INSIGHT

Practical Pearls

Result Bands

<0.01%

0.01-0.09%

0.1-0.99%

>=1%

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.

OpiCalc Medical Oncology ModuleHaematological Malignancies2026

CLINICAL INSIGHT

Background

Context

MRD Assessment Framework is included in the oncology module as a structured decision-support tool for haematological malignancies workflows.

No clinical reference data available.